L. T. Gooljarsingh

A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues

A. King, R. Copeland, P. Tummino, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Functionalized analogues of 5,8,10-trideazafolate as potential inhibitors of GAR Tfase or AICAR Tfase.

D. Boger, S. Benkovic, L. T. Gooljarsingh, 1997, Bioorganic & medicinal chemistry.

10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.

D. Boger, I. Wilson, S. Benkovic, 2002, Bioorganic & medicinal chemistry.

Design, synthesis, and evaluation of potential GAR and AICAR transformylase inhibitors.

D. Boger, S. Benkovic, L. T. Gooljarsingh, 1998, Bioorganic & medicinal chemistry.

Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.

Stephen J Benkovic, Yan Zhang, Ali Tavassoli, 2003, Biochemistry.

Localization of GAR transformylase in Escherichia coli and mammalian cells

S. Benkovic, S. Gilroy, L. T. Gooljarsingh, 2001, Proceedings of the National Academy of Sciences of the United States of America.

The transformylase enzymes of de novo purine biosynthesis

S. Benkovic, J. Shim, L. T. Gooljarsingh, 1984 .

Characterization of an exosite binding inhibitor of matrix metalloproteinase 13

G. Fields, Frank T. Coppo, P. Tummino, 2007, Protein science : a publication of the Protein Society.